Contract Research

The drug research and development process is highly complex, yet essential for delivering safe and effective therapies to patients. Even though the process is well defined, drug development programs are fundamentally different for each product.

To help our clients navigate this process, Charles River offers a wide range of products and services that span the entire drug discovery and development continuum and can be tailored to specific research conditions.

Charles River’s in vitro  facility located in Skokie, IL, specializes in large molecule bioanalysis and genetic and in vitro toxicology for pharmaceutical, biotechnology, chemical, agrochemical and food companies.

Laboratories and Facilities

  • GLP and non-GLP study conduct
  • Genetic and in vitro toxicology
  • Large molecule bioanalysis


Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Our proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders.